Primary Outcome Measures:
- Weaning Acceleration [ Time Frame: Time weaning measured in hours ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Strenght and ventilatory variables [ Time Frame: Time weaning measured in hours ] [ Designated as safety issue: Yes ]
- After at least 48 hours on CMV, the patients in PSV were randomized into two groups: control group and IMT group.
- Before each protocol session, the cardiorespiratory variables such as f, HR, MAP and SpO2, as well as the support ventilatory variables such as PSV, PEEP, FiO2 and trigger sensitivity, were recorded.
- After collecting the first records, the patients were placed in a 45º Fowler position, and variables MIP and MEP were collected with a unidirectional valve, as well as f, VE, Vt and f/Vt.
- The IMT group was trained using the threshold IMT device with a 40% MIP load. Each training session consisted of 5 sets with 10 breaths, twice a day. Supplementary oxygen was added if necessary during the protocol. The training was cancelled in the presence of tachyarrhythmia, reduction of SpO2 under 85% and in the presence of fatigue signs or respiratory dysfunction. In this case, the patients returned to MV. All cardiorespiratory variables (f, HR, MAP and SpO2) were recorded again one minute after the end of the protocol. The same data were recorded in the control group before and after the protocol, but the patients were not trained with the threshold IMT device.
- All patients were followed up until weaning. During this period, laboratory tests were recorded, such as:
potassium, sodium and magnesium as well as arterial gasometry, calculating the partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio.